Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Contraception and Contraceptive Drugs

  Free Subscription


Articles published in Obstet Gynecol

Retrieve available abstracts of 94 articles:
HTML format



Single Articles


    June 2022
  1. ROE AH, Abernathy A, Flynn AN, McAllister A, et al
    Utility and Limitations of Human Chorionic Gonadotropin Levels for Remote Follow-up After Medical Management of Early Pregnancy Loss.
    Obstet Gynecol. 2022;139:1149-1151.
    PubMed     Abstract available


  2. BIGGS MA, Ehrenreich K, Morris N, Blanchard K, et al
    Comprehension of an Over-the-Counter Drug Facts Label Prototype for a Mifepristone and Misoprostol Medication Abortion Product.
    Obstet Gynecol. 2022;139:1111-1122.
    PubMed     Abstract available


    May 2022
  3. PAKEY J, Nassim JS, Reynolds RV
    Hormonal Intrauterine Devices and Acne.
    Obstet Gynecol. 2022;139:919-921.
    PubMed    


  4. PETERSON SF, Lerma K, Shaw KA, Blumenthal PD, et al
    Cervical Preparation Using Ulipristal Acetate With Adjunct Misoprostol in Second-Trimester Surgical Abortions.
    Obstet Gynecol. 2022;139:907-909.
    PubMed    


  5. HARMON QE, Patchel SA, Zhao S, Umbach DM, et al
    Depot Medroxyprogesterone Acetate Use and the Development and Progression of Uterine Leiomyoma.
    Obstet Gynecol. 2022;139:797-807.
    PubMed     Abstract available


  6. RODRIGUEZ MI, Manibusan B, Kaufman M, McConnell KJ, et al
    Association of Pharmacist Prescription of Contraception With Breaks in Coverage.
    Obstet Gynecol. 2022;139:781-787.
    PubMed     Abstract available


  7. GOLDBERG AB, Fulcher IR, Fortin J, Hofer RK, et al
    Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location.
    Obstet Gynecol. 2022;139:771-780.
    PubMed     Abstract available


  8. KOPP-KALLNER H, Linder M, Cesta CE, Segovia Chacon S, et al
    Method of Hormonal Contraception and Protective Effects Against Ectopic Pregnancy.
    Obstet Gynecol. 2022;139:764-770.
    PubMed     Abstract available


    April 2022
  9. LAZORWITZ A, Pena M, Sheeder J, Teal S, et al
    Effect of Topiramate on Serum Etonogestrel Concentrations Among Contraceptive Implant Users.
    Obstet Gynecol. 2022;139:579-587.
    PubMed     Abstract available


  10. QURESHEY EJ, Chauhan SP, Wagner SM, Batiste O, et al
    Educational Multimedia Tool Compared With Routine Care for the Uptake of Postpartum Long-Acting Reversible Contraception in Individuals With High-Risk Pregnancies: A Randomized Controlled Trial.
    Obstet Gynecol. 2022;139:571-578.
    PubMed     Abstract available


    March 2022
  11. BRANT AR, Batur P, Arrigain S, Lopez R, et al
    Out-of-Pocket Expenditures for Contraceptives During State Medicaid Expansion, 2013-2016.
    Obstet Gynecol. 2022 Mar 10. pii: 00006250-990000000-00411.
    PubMed    


  12. BURGER T, Li J, Zhao Q, Schreiber CA, et al
    Association of Obesity With Longer Time to Pregnancy.
    Obstet Gynecol. 2022 Mar 10. pii: 00006250-990000000-00400.
    PubMed     Abstract available


  13. GARIEPY AM, Lewis C, Zuckerman D, Tancredi DJ, et al
    Patient-Centered Safety Outcomes After Hysteroscopic Compared With Laparoscopic Sterilization.
    Obstet Gynecol. 2022;139:423-432.
    PubMed     Abstract available


  14. DANVERS AA, Evans TA
    Risk of Sterilization Regret and Age: An Analysis of the National Survey of Family Growth, 2015-2019.
    Obstet Gynecol. 2022;139:433-439.
    PubMed     Abstract available


    February 2022
  15. STEENLAND MW, Rodriguez MI, Cohen JL
    Changes in the Supply Duration of Combined Oral Contraception During the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Obstet Gynecol. 2022 Feb 3. pii: 00006250-990000000-00386.
    PubMed    



  16. Patient-Centered Contraceptive Counseling: ACOG Committee Statement Number 1.
    Obstet Gynecol. 2022;139:350-353.
    PubMed    


    November 2021
  17. MAGNUSSON BM, Christensen SR, Tanner AB, Eyring JB, et al
    Accessibility of Pharmacist-Prescribed Contraceptives in Utah.
    Obstet Gynecol. 2021 Nov 4. pii: 00006250-990000000-00334.
    PubMed     Abstract available


    October 2021
  18. BRANT AR, Kollikonda S, Yao M, Mei L, et al
    Use of Immediate Postpartum Long-Acting Reversible Contraception Before and After a State Policy Mandated Inpatient Access.
    Obstet Gynecol. 2021 Oct 7. pii: 00006250-990000000-00308.
    PubMed     Abstract available


  19. BURLANDO AM, Flynn AN, Gutman S, McAllister A, et al
    The Role of Subcutaneous Depot Medroxyprogesterone Acetate in Equitable Contraceptive Care: A Lesson From the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Obstet Gynecol. 2021;138:574-577.
    PubMed     Abstract available


  20. BOUMA-JOHNSTON H, Arora KS
    Website Review of Variation in Individual State Medicaid Sterilization Policies.
    Obstet Gynecol. 2021;138:578-579.
    PubMed    


  21. BOHN JA, Bullard KA, Rodriguez MI, Ecker AM, et al
    Stepwise Approach to the Management of Endometriosis-Related Dysmenorrhea: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2021;138:557-564.
    PubMed     Abstract available


    August 2021
  22. WU JP, Zhang J, McKee M, Akobirshoev I, et al
    Contraceptive Provision and Quality Care Measures for Insured Individuals in Massachusetts Who Are Deaf or Hard of Hearing.
    Obstet Gynecol. 2021 Aug 5. pii: 00006250-990000000-00251.
    PubMed     Abstract available


  23. SCHAUB AM, Pisarska MD, Wright KN
    Intrauterine Adhesions After Chlamydia Infection With a Levonorgestrel-Releasing Intrauterine Device in Place.
    Obstet Gynecol. 2021 Aug 5. pii: 00006250-990000000-00258.
    PubMed     Abstract available



  24. Access to Postabortion Contraception: ACOG Committee Opinion, Number 833.
    Obstet Gynecol. 2021;138:e91-e95.
    PubMed     Abstract available



  25. Access to Postabortion Contraception: ACOG Committee Opinion Summary, Number 833.
    Obstet Gynecol. 2021;138:324-325.
    PubMed     Abstract available


    July 2021
  26. BAKENRA A, Gero A, Sanders J, Simmons R, et al
    Pregnancy Risk by Frequency and Timing of Unprotected Intercourse Before Intrauterine Device Placement for Emergency Contraception.
    Obstet Gynecol. 2021;138:79-84.
    PubMed     Abstract available


  27. ARORA KS, Ponsaran R, Morello L, Katabi L, et al
    Obstetrician-Gynecologists' Practices in Postpartum Sterilization Without a Valid Medicaid Consent Form.
    Obstet Gynecol. 2021;138:66-72.
    PubMed     Abstract available


    June 2021

  28. Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.
    Obstet Gynecol. 2021;137:e100-e115.
    PubMed     Abstract available



  29. Access to Postpartum Sterilization: ACOG Committee Opinion, Number 827.
    Obstet Gynecol. 2021;137:e169-e176.
    PubMed     Abstract available


    May 2021
  30. HAMDAOUI N, Cardinale C, Fabre C, Baumstarck K, et al
    Pain Associated With Cervical Priming for First-Trimester Surgical Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2021 May 6. pii: 00006250-990000000-00191.
    PubMed     Abstract available


    April 2021
  31. COLEMAN-MINAHAN K, Ela EJ, White K, Grossman D, et al
    Contraindications to Hormonal Contraception Among Postpartum Women in Texas.
    Obstet Gynecol. 2021 Apr 8. pii: 00006250-990000000-00175.
    PubMed     Abstract available


  32. ALLANSON ER, Copson S, Spilsbury K, Criddle S, et al
    Pretreatment With Mifepristone Compared With Misoprostol Alone for Delivery After Fetal Death Between 14 and 28 Weeks of Gestation: A Randomized Controlled Trial.
    Obstet Gynecol. 2021 Apr 8. pii: 00006250-990000000-00158.
    PubMed     Abstract available


  33. COHEN M, Edelman A, Bellussi F, Berghella V, et al
    Cochrane Review Summaries-April 2021.
    Obstet Gynecol. 2021;137:747-749.
    PubMed     Abstract available


    March 2021
  34. MEURICE ME, Lovio M, Chang JJ, Perry R, et al
    Contraception Choice Among Those Seeking Abortion for Fetal Indication or Management of Pregnancy Loss.
    Obstet Gynecol. 2021 Mar 10. pii: 00006250-990000000-00125.
    PubMed     Abstract available


  35. BORAAS CM, Sanders JN, Schwarz EB, Thompson I, et al
    Risk of Pregnancy With Levonorgestrel-Releasing Intrauterine System Placement 6-14 Days After Unprotected Sexual Intercourse.
    Obstet Gynecol. 2021 Mar 10. pii: 00006250-990000000-00136.
    PubMed    



  36. Health Care for Transgender and Gender Diverse Individuals: ACOG Committee Opinion, Number 823.
    Obstet Gynecol. 2021;137:e75-e88.
    PubMed     Abstract available


    February 2021
  37. AKTURK HK
    Locating Hormone-Releasing Contraceptive Implants Using Near-Infrared Light.
    Obstet Gynecol. 2021 Feb 4. pii: 00006250-990000000-00117.
    PubMed     Abstract available


  38. ROLAND N, Drouin J, Desplas D, Cuenot F, et al
    Effects of the Coronavirus Disease 2019 (COVID-19) Lockdown on the Use of Contraceptives and Ovulation Inductors in France.
    Obstet Gynecol. 2021 Feb 4. pii: 00006250-990000000-00100.
    PubMed    


    January 2021

  39. Options for Prevention and Management of Menstrual Bleeding in Adolescent Patients Undergoing Cancer Treatment: ACOG Committee Opinion, Number 817.
    Obstet Gynecol. 2021;137:e7-e15.
    PubMed     Abstract available


    December 2020
  40. GOLDMAN AR, Porsch L, Hintermeister A, Dragoman M, et al
    Transcutaneous Electrical Nerve Stimulation to Reduce Pain With Medication Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2020 Dec 3. doi: 10.1097/AOG.0000000000004208.
    PubMed     Abstract available


    November 2020

  41. Gynecologic Considerations for Adolescents and Young Women With Cardiac Conditions: ACOG Committee Opinion, Number 813.
    Obstet Gynecol. 2020;136:e90-e99.
    PubMed     Abstract available



  42. Gynecologic Considerations for Adolescents and Young Women With Cardiac Conditions: ACOG Committee Opinion Summary, Number 813.
    Obstet Gynecol. 2020;136:1072-1073.
    PubMed     Abstract available


    October 2020
  43. FERRIES-ROWE E, Corey E, Archer JS
    Primary Dysmenorrhea: Diagnosis and Therapy.
    Obstet Gynecol. 2020 Oct 8. doi: 10.1097/AOG.0000000000004096.
    PubMed     Abstract available



  44. Medication Abortion Up to 70 Days of Gestation: ACOG Practice Bulletin Summary, Number 225.
    Obstet Gynecol. 2020;136:855-858.
    PubMed     Abstract available


    September 2020
  45. BERKLEY HH, Greene HL, Wittenberger MD
    Mifepristone Combination Therapy Compared With Misoprostol Monotherapy for the Management of Miscarriage: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2020 Sep 10. doi: 10.1097/AOG.0000000000004063.
    PubMed     Abstract available


    August 2020
  46. CREININ MD, Grossman DA
    Medication Abortion Up to 70 Days of Gestation.
    Obstet Gynecol. 2020 Aug 12. doi: 10.1097/AOG.0000000000004082.
    PubMed     Abstract available


  47. LEININGER WM, Gupta P
    One Hundred Years of Women's Suffrage: Health Care Advocacy, and Why We Vote.
    Obstet Gynecol. 2020;136:349-353.
    PubMed     Abstract available


    July 2020
  48. EDELMAN AB, Kaneshiro B, Simmons KB, Hauschildt JL, et al
    Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users: A Randomized Controlled Trial.
    Obstet Gynecol. 2020 Jul 9. doi: 10.1097/AOG.0000000000003896.
    PubMed     Abstract available


    June 2020
  49. BARBIERI JS, Mitra N, Margolis DJ, Harper CC, et al
    Influence of Contraception Class on Incidence and Severity of Acne Vulgaris.
    Obstet Gynecol. 2020;135:1306-1312.
    PubMed     Abstract available


  50. SPOTNITZ ME, Natarajan K, Ryan PB, Westhoff CL, et al
    In Reply.
    Obstet Gynecol. 2020;135:1487.
    PubMed    


  51. SEL G, Yasar O, Aynali B, Dincer F, et al
    Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users.
    Obstet Gynecol. 2020;135:1486-1487.
    PubMed    


  52. SIMON JA, Al-Hendy A, Archer DF, Barnhart KT, et al
    Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.
    Obstet Gynecol. 2020;135:1313-1326.
    PubMed     Abstract available


  53. FLOYD JL, Beasley AD, Swaim LS, Turrentine MA, et al
    Association of Immediate Postpartum Etonogestrel Implant Insertion and Venous Thromboembolism.
    Obstet Gynecol. 2020;135:1275-1280.
    PubMed     Abstract available


    May 2020

  54. Gynecologic Management of Adolescents and Young Women With Seizure Disorders: ACOG Committee Opinion, Number 806.
    Obstet Gynecol. 2020;135:e213-e220.
    PubMed     Abstract available



  55. Gynecologic Management of Adolescents and Young Women With Seizure Disorders: ACOG Committee Opinion Summary, Number 806.
    Obstet Gynecol. 2020;135:1242-1243.
    PubMed     Abstract available


    April 2020
  56. LATHROP E, Hurst S, Mendoza Z, Zapata LB, et al
    Final Program Data and Factors Associated With Long-Acting Reversible Contraception Removal: The Zika Contraception Access Network.
    Obstet Gynecol. 2020 Apr 9. doi: 10.1097/AOG.0000000000003835.
    PubMed     Abstract available


  57. DARWIN KC, Johnson CT
    Desired Sterilization Procedure at the Time of Cesarean Delivery According to Insurance Status.
    Obstet Gynecol. 2020;135:976.
    PubMed    


  58. CREININ MD, Hou MY, Dalton L, Steward R, et al
    In Reply.
    Obstet Gynecol. 2020;135:970-971.
    PubMed    


  59. VALLEY MT
    Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2020;135:970.
    PubMed    


  60. BUTTERFIELD-KALK CR
    Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2020;135:970.
    PubMed    


  61. DELGADO G, Davenport M, Harrison M
    Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2020;135:969-970.
    PubMed    


    March 2020
  62. STEINBERG JR, Harrison EY, Boudreaux M
    Psychosocial Factors Associated With Postpartum Contraceptive Method Use After an Unintended Birth.
    Obstet Gynecol. 2020 Mar 10. doi: 10.1097/AOG.0000000000003745.
    PubMed     Abstract available


    February 2020
  63. SPOTNITZ ME, Natarajan K, Ryan PB, Westhoff CL, et al
    Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users.
    Obstet Gynecol. 2020 Feb 9. doi: 10.1097/AOG.0000000000003656.
    PubMed     Abstract available


  64. MACAFEE LK, Harfmann RF, Cannon LM, Kolenic G, et al
    Sexual and Reproductive Health Characteristics of Women in Substance Use Treatment in Michigan.
    Obstet Gynecol. 2020;135:361-369.
    PubMed     Abstract available


    January 2020

  65. Pharmacist Provision of Hormonal Contraception in the Oregon Medicaid Population: Correction.
    Obstet Gynecol. 2020;135:222.
    PubMed    


    December 2019
  66. CREININ MD, Hou MY, Dalton L, Steward R, et al
    Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2019 Dec 5. doi: 10.1097/AOG.0000000000003620.
    PubMed     Abstract available


    October 2019

  67. Over-the-Counter Access to Hormonal Contraception: ACOG Committee Opinion, Number 788.
    Obstet Gynecol. 2019;134:e96-e105.
    PubMed     Abstract available



  68. Over-the-Counter Access to Hormonal Contraception: ACOG Committee Opinion Summary, Number 788.
    Obstet Gynecol. 2019;134:886-887.
    PubMed     Abstract available


    September 2019

  69. Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding: ACOG COMMITTEE OPINION, Number 785.
    Obstet Gynecol. 2019;134:e71-e83.
    PubMed     Abstract available



  70. Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding: ACOG COMMITTEE OPINION SUMMARY, Number 785.
    Obstet Gynecol. 2019;134:658-659.
    PubMed     Abstract available


    June 2019
  71. AINSWORTH AJ, Baumgarten SC, Bakkum-Gamez JN, Vachon CM, et al
    Tubal Ligation and Age at Natural Menopause.
    Obstet Gynecol. 2019;133:1247-1254.
    PubMed     Abstract available


    April 2019
  72. HATFIELD JL
    Ulipristal Acetate for Symptomatic Uterine Leiomyomas: Neither the Long-Awaited Panacea, nor the Opening of Pandora's Box.
    Obstet Gynecol. 2019 Apr 5. doi: 10.1097/AOG.0000000000003238.
    PubMed    



  73. ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
    Obstet Gynecol. 2019;133:e279-e284.
    PubMed     Abstract available


    March 2019
  74. WONG S, Naresh A
    Etonogestrel Subdermal Implant-Associated Regression of Endometrial Intraepithelial Neoplasia.
    Obstet Gynecol. 2019 Mar 11. doi: 10.1097/AOG.0000000000003152.
    PubMed     Abstract available


  75. SUDHOF L, Shah NT
    In Pursuit of Value-Based Maternity Care.
    Obstet Gynecol. 2019;133:541-551.
    PubMed     Abstract available


  76. TEPPER NK, Jeng G, Curtis KM, Boutot ME, et al
    Venous Thromboembolism Among Women Initiating Depot Medroxyprogesterone Acetate Immediately Postpartum.
    Obstet Gynecol. 2019;133:533-540.
    PubMed     Abstract available


  77. BENLOLO S, Papillon-Smith J, Murji A
    Ulipristal Acetate for Disseminated Peritoneal Leiomyomatosis.
    Obstet Gynecol. 2019;133:434-436.
    PubMed     Abstract available



  78. ACOG Practice Bulletin No. 208: Benefits and Risks of Sterilization.
    Obstet Gynecol. 2019;133:e194-e207.
    PubMed     Abstract available



  79. ACOG Practice Bulletin No. 208 Summary: Benefits and Risks of Sterilization.
    Obstet Gynecol. 2019;133:592-594.
    PubMed     Abstract available


    February 2019
  80. GROSSMAN D, Grindlay K, Altshuler AL, Schulkin J, et al
    Induced Abortion Provision Among a National Sample of Obstetrician-Gynecologists.
    Obstet Gynecol. 2019 Feb 4. doi: 10.1097/AOG.0000000000003110.
    PubMed     Abstract available


  81. MAO J, Guiahi M, Chudnoff S, Schlegel P, et al
    Seven-Year Outcomes After Hysteroscopic and Laparoscopic Sterilizations.
    Obstet Gynecol. 2019;133:323-331.
    PubMed     Abstract available


  82. DIANAT S, Fox E, Ahrens KA, Upadhyay UD, et al
    Side Effects and Health Benefits of Depot Medroxyprogesterone Acetate: A Systematic Review.
    Obstet Gynecol. 2019;133:332-341.
    PubMed     Abstract available


    January 2019

  83. ACOG Committee Opinion No. 762: Prepregnancy Counseling.
    Obstet Gynecol. 2019;133:e78-e89.
    PubMed     Abstract available



  84. ACOG Committee Opinion No. 762 Summary: Prepregnancy Counseling.
    Obstet Gynecol. 2019;133:228-230.
    PubMed     Abstract available


  85. THORNE NB, Soderborg TK, Glover JJ, Hoffecker L, et al
    Reproductive Health Care in Catholic Facilities: A Scoping Review.
    Obstet Gynecol. 2019;133:105-115.
    PubMed     Abstract available


    December 2018

  86. ACOG Committee Opinion No. 760: Dysmenorrhea and Endometriosis in the Adolescent.
    Obstet Gynecol. 2018;132:e249-e258.
    PubMed     Abstract available



  87. ACOG Committee Opinion No. 760 Summary: Dysmenorrhea and Endometriosis in the Adolescent.
    Obstet Gynecol. 2018;132:1517-1518.
    PubMed     Abstract available


    November 2018

  88. ACOG Practice Bulletin No. 200 Summary: Early Pregnancy Loss.
    Obstet Gynecol. 2018;132:1311-1313.
    PubMed     Abstract available


    October 2018
  89. CARR BR, Stewart EA, Archer DF, Al-Hendy A, et al
    Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002933.
    PubMed     Abstract available


  90. SONALKAR S, Hunter T, Gurney EP, McAllister A, et al
    A Decision Analysis Model of 1-Year Effectiveness of Intended Postplacental Compared With Intended Delayed Postpartum Intrauterine Device Insertion.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002926.
    PubMed     Abstract available


  91. LIU JH, Soper D, Lukes A, Gee P, et al
    Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002942.
    PubMed     Abstract available


    August 2018

  92. Early Pregnancy Loss.
    Obstet Gynecol. 2018 Aug 28. doi: 10.1097/AOG.0000000000002899.
    PubMed     Abstract available



  93. ACOG Committee Opinion No. 747: Gynecologic Issues in Children and Adolescent Cancer Patients and Survivors.
    Obstet Gynecol. 2018;132:e67-e77.
    PubMed     Abstract available


    May 2018
  94. AKERS AY, Harding J, Perriera LK, Schreiber C, et al
    Satisfaction With the Intrauterine Device Insertion Procedure Among Adolescent and Young Adult Women.
    Obstet Gynecol. 2018 May 7. doi: 10.1097/AOG.0000000000002596.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: